Your browser doesn't support javascript.
loading
Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin®) in paediatric patients under 6 years of age with severe von Willebrand disease.
Gouider, Emna; Klukowska, Anna; Maes, Philip; Platokouki, Helen; Pujol, Sonia; Henriet, Céline; Bridey, Françoise; Goudemand, Jenny.
Afiliação
  • Gouider E; Haemophilia Centre, Aziza Othmana Hospital, University Tunis El Manar, Tunis, Tunisia.
  • Klukowska A; Department of Oncology, Paediatric Haematology, Clinical Transplantology and Paediatrics of Warsaw Medical University, Warsaw, Poland.
  • Maes P; University Hospital of Antwerp, Paediatric Haematology and Oncology Department, Antwerp, Belgium.
  • Platokouki H; Haemophilia-Centre-Haemostasis Unit, Aghia Sophia Children's Hospital, Athens, Greece.
  • Pujol S; Clinical Development, Laboratoire Français du Fractionnement et des Biotechnologies (LFB), Les Ulis, France.
  • Henriet C; Clinical Development, Laboratoire Français du Fractionnement et des Biotechnologies (LFB), Les Ulis, France.
  • Bridey F; Formerly Clinical Development, Laboratoire Français du Fractionnement et des Biotechnologies (LFB), Les Ulis, France.
  • Goudemand J; Department of Haemostasis and Transfusion, Lille University Hospital, Lille, France.
Blood Transfus ; 21(1): 83-92, 2023 01.
Article em En | MEDLINE | ID: mdl-35543677
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / Hemostáticos / Anafilaxia Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / Hemostáticos / Anafilaxia Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article